SCHEMBL5601356

SCHEMBL5601356

CN(C)C(Cl)CCOc1ccc(Cc2nccn2C)cc1OCCC(Cl)N(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.39
CHRNA4 P43681 1/20 0.39
TRPM5 Q9NZQ8 1/20 0.36
LMNA P02545 4/20 0.35
ALDH1A1 P00352 2/20 0.35
POLB P06746 2/20 0.33
MAPK1 P28482 4/20 0.32
MEN1 O00255 4/20 0.32
KMT2A Q03164 4/20 0.32
TSHR P16473 3/20 0.32
CYP3A4 P08684 3/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
CYP1A2 P05177 2/20 0.32
CYP2C9 P11712 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
LTA4H P09960 1/20 0.32
ADRA2A P08913 1/20 0.32
ADORA3 P0DMS8 1/20 0.32
CHRM1 P11229 1/20 0.32
DRD1 P21728 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5601022 0.88 LMNA (0.36) CHRNB2CHRNA4TRPM5LMNAALDH1A1
SCHEMBL5599079 0.85 KMT2A (0.42) CHRNB2CHRNA4LMNAMAPK1MEN1
SCHEMBL5601407 0.75 MEN1 (0.44) CHRNB2CHRNA4LMNAMAPK1MEN1
SCHEMBL5600396 0.74 POLB (0.40) LMNAALDH1A1POLBMEN1KMT2A
SCHEMBL1008065 0.73 CA2 (0.56) LMNAALDH1A1POLBMAPK1MEN1
SCHEMBL5599736 0.72 L3MBTL1 (0.35) CHRNB2CHRNA4KMT2APDE4DMAPT
Bromide SCHEMBL2192386 0.72 CA2 (0.54) LMNAALDH1A1POLBMAPK1MEN1
SCHEMBL5599937 0.70 CHRNB2 (0.35) CHRNB2CHRNA4LMNASMN1; SMN2HTT
SCHEMBL6672328 0.70 TRPM5 (0.32) CHRNB2CHRNA4TRPM5LMNAMEN1
SCHEMBL6649371 0.69 HTR1A (0.32) CHRNB2CHRNA4TRPM5LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1103243-B1 UTILIZATION OF ARYL(OR HETEROARYL)AZOLYLCARBINOL DERIVATIVES FOR THE TREATMENT OF TROUBLES MEDIATED BY AN EXCESS OF SUBSTANCE P ESTEVE LABOR DR (ES) 2004-01-07 EP claimed
EP-1746986-A1 ACTIVE SUBSTANCE COMBINATION COMPRISING A CARBINOL COMBINED TO AT LEAST AN NSAID LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2007-01-31 EP disclosed
WO-2005097099-A1 ACTIVE SUBSTANCE COMBINATION COMPRISING A CARBINOL COMBINED TO AT LEAST AN NSAID LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2005-10-20 WO disclosed